Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31 | 20 | 8 | 3 | 7 |
| Receivables | 31 | 38 | 30 | 25 | 22 |
| Inventories | 26 | 51 | 52 | 53 | 54 |
| TOTAL | $185 | $317 | $259 | $254 | $350 |
| Non-Current Assets | |||||
| PPE Net | 14 | 14 | 15 | 17 | 19 |
| Other Non-Current Assets | 16 | 16 | 16 | 16 | 19 |
| TOTAL | $29 | $29 | $30 | $32 | $38 |
| Total Assets | $214 | $346 | $289 | $287 | $388 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,577 | 2,260 | 2,000 | 1,794 | 1,492 |
| Accounts payable and accrued liabilities | 1,010 | 980 | 1,081 | 974 | 989 |
| Accrued Expenses | 1,014 | 997 | 1,157 | 1,164 | 1,130 |
| Other current liabilities | 49 | 47 | 47 | 62 | 143 |
| TOTAL | $4,649 | $4,284 | $4,286 | $3,994 | $3,754 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 43 | 167 | 190 | 259 | 208 |
| TOTAL | $43 | $167 | $190 | $259 | $208 |
| Total Liabilities | $4,691 | $4,451 | $4,475 | $4,253 | $3,962 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 368,241 | 255,392 | 193,377 | 106,895 | 106,895 |
| Common Shares | 295 | 228 | 147 | 106 | 80 |
| Retained earnings | -53,359 | -52,285 | -51,641 | -50,987 | -49,912 |
| TOTAL | $-4,477 | $-4,104 | $-4,186 | $-3,966 | $-3,574 |
| Total Liabilities And Equity | $214 | $346 | $289 | $287 | $388 |